Connect with UMGCC
Email page
Print page
Email page
Print page
Loading
- Patient Care
- Being Admitted
- UMGCC Directory
- Schedule an Appointment
- Ask the Expert
- Patient Education
- Parking, Lodging and Restaurants
- Podcasts
- Audio/Video Library
Related Resources- Center for Image Renewal
- Clinical Trials
- Contact Us
- Patient Web Pages
Home >Information for Patients > Dictionary Index
Dictionary of Cancer Terms
View in English: Lexatumumab
Lexatumumab
Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Se une con una proteína que se llama TRAIL-R2 de la superficie de algunas células tumorales, lo que podría destruir estas células. El lexatumumab es un tipo de anticuerpo monoclonal. También se llama anti-TRAIL R2 mAb HGS-ETR2 y HGS-ETR2.
Source: National Cancer Institute Dictionary of Cancer Terms, available at www.cancer.gov/dictionary.
Email this Page
Print this Page
If you would like to make an appointment or talk to someone about our services, please call 1-800-888-8823.
Physicians can call our dedicated consultation referral service at 1-800-373-4111.
Physicians can call our dedicated consultation referral service at 1-800-373-4111.
© 2011 University of Maryland Greenebaum Cancer Center. All rights reserved.
22 S. Greene Street, Baltimore, MD 21201
22 S. Greene Street, Baltimore, MD 21201
